MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types

The mitogen-activated protein kinase (MAPK) pathways are ubiquitous in cellular signaling and are essential for proper biological functions. Disruptions in this signaling axis can lead to diseases such as the development of cancer. In this review, we discuss members of the MAP3K family and correlate...

Full description

Bibliographic Details
Main Authors: Khoa Nguyen, Minh N. Tran, Andrew Rivera, Thomas Cheng, Gabrielle O. Windsor, Abraham B. Chabot, Jane E. Cavanaugh, Bridgette M. Collins-Burow, Sean B. Lee, David H. Drewry, Patrick T. Flaherty, Matthew E. Burow
Format: Article
Language:English
Published: IMR Press 2022-05-01
Series:Frontiers in Bioscience-Landmark
Subjects:
Online Access:https://www.imrpress.com/journal/FBL/27/5/10.31083/j.fbl2705167
_version_ 1828363780935909376
author Khoa Nguyen
Minh N. Tran
Andrew Rivera
Thomas Cheng
Gabrielle O. Windsor
Abraham B. Chabot
Jane E. Cavanaugh
Bridgette M. Collins-Burow
Sean B. Lee
David H. Drewry
Patrick T. Flaherty
Matthew E. Burow
author_facet Khoa Nguyen
Minh N. Tran
Andrew Rivera
Thomas Cheng
Gabrielle O. Windsor
Abraham B. Chabot
Jane E. Cavanaugh
Bridgette M. Collins-Burow
Sean B. Lee
David H. Drewry
Patrick T. Flaherty
Matthew E. Burow
author_sort Khoa Nguyen
collection DOAJ
description The mitogen-activated protein kinase (MAPK) pathways are ubiquitous in cellular signaling and are essential for proper biological functions. Disruptions in this signaling axis can lead to diseases such as the development of cancer. In this review, we discuss members of the MAP3K family and correlate their mRNA expression levels to patient survival outcomes in different cancers. Furthermore, we highlight the importance of studying the MAP3K family due to their important roles in the larger, overall MAPK pathway, relationships with cancer progression, and the understudied status of these kinases.
first_indexed 2024-04-14T05:06:50Z
format Article
id doaj.art-ae4f71ffb677486896b12ea1d2ecc0c0
institution Directory Open Access Journal
issn 2768-6701
language English
last_indexed 2024-04-14T05:06:50Z
publishDate 2022-05-01
publisher IMR Press
record_format Article
series Frontiers in Bioscience-Landmark
spelling doaj.art-ae4f71ffb677486896b12ea1d2ecc0c02022-12-22T02:10:41ZengIMR PressFrontiers in Bioscience-Landmark2768-67012022-05-0127516710.31083/j.fbl2705167S2768-6701(22)00518-4MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer TypesKhoa Nguyen0Minh N. Tran1Andrew Rivera2Thomas Cheng3Gabrielle O. Windsor4Abraham B. Chabot5Jane E. Cavanaugh6Bridgette M. Collins-Burow7Sean B. Lee8David H. Drewry9Patrick T. Flaherty10Matthew E. Burow11Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USADepartment of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USADepartment of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USADepartment of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USADepartment of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USADepartment of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USADepartment of Pharmacological Sciences, Division of Medicinal Chemistry, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA 15218, USADepartment of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USADepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USAUNC Eshelman School of Pharmacy and UNC Lineberger Comprehensive Cancer Center, Chemical Biology and Medicinal Chemistry Division, SGC-UNC, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USADepartment of Pharmacological Sciences, Division of Medicinal Chemistry, Mylan School of Pharmacy, Duquesne University, Pittsburgh, PA 15218, USADepartment of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USAThe mitogen-activated protein kinase (MAPK) pathways are ubiquitous in cellular signaling and are essential for proper biological functions. Disruptions in this signaling axis can lead to diseases such as the development of cancer. In this review, we discuss members of the MAP3K family and correlate their mRNA expression levels to patient survival outcomes in different cancers. Furthermore, we highlight the importance of studying the MAP3K family due to their important roles in the larger, overall MAPK pathway, relationships with cancer progression, and the understudied status of these kinases.https://www.imrpress.com/journal/FBL/27/5/10.31083/j.fbl2705167map kinasesmapkmap3kunderstudied kinasedark kinomeilluminating the druggable genomecancer
spellingShingle Khoa Nguyen
Minh N. Tran
Andrew Rivera
Thomas Cheng
Gabrielle O. Windsor
Abraham B. Chabot
Jane E. Cavanaugh
Bridgette M. Collins-Burow
Sean B. Lee
David H. Drewry
Patrick T. Flaherty
Matthew E. Burow
MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types
Frontiers in Bioscience-Landmark
map kinases
mapk
map3k
understudied kinase
dark kinome
illuminating the druggable genome
cancer
title MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types
title_full MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types
title_fullStr MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types
title_full_unstemmed MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types
title_short MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types
title_sort map3k family review and correlations with patient survival outcomes in various cancer types
topic map kinases
mapk
map3k
understudied kinase
dark kinome
illuminating the druggable genome
cancer
url https://www.imrpress.com/journal/FBL/27/5/10.31083/j.fbl2705167
work_keys_str_mv AT khoanguyen map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT minhntran map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT andrewrivera map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT thomascheng map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT gabrielleowindsor map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT abrahambchabot map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT janeecavanaugh map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT bridgettemcollinsburow map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT seanblee map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT davidhdrewry map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT patricktflaherty map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes
AT mattheweburow map3kfamilyreviewandcorrelationswithpatientsurvivaloutcomesinvariouscancertypes